🔎 Trials Near Me

Nyumbani › Mesothelioma

Majaribio ya kliniki ya Mesothelioma yanayovutia washiriki nchini Marekani

Masomo 45 ya Mesothelioma yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

SW-682 in Advanced Solid Tumors

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06251310

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

InaajiriUtafiti wa uchunguzi
Umri 2 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT00242723

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

InaajiriUtafiti wa uchunguzi
Umri 2 hadi 100 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT01950572

Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1

InaajiriUtafiti wa uchunguzi
Umri 2 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03830229

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05932199

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07277413

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT04981119

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Inaajiri
Umri 30 hadi 85 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06037941

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06057935

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07705334

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06566079

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT04969315

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05732831

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT05245500

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04104776

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

InaajiriHatua 1
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT07192900

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT05579366

Lead-212 PSV359 Therapy for Patients With Solid Tumors

InaajiriHatua 1/2
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 19 hadi 110 · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT02012699

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Jun 2026 · NCT05568680

CT-95 in Advanced Cancers Associated With Mesothelin Expression

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Jun 2026 · NCT06756035

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.